These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10696914)

  • 1. Copolymer 1 inhibits experimental autoimmune uveoretinitis.
    Zhang M; Chan CC; Vistica B; Hung V; Wiggert B; Gery I
    J Neuroimmunol; 2000 Mar; 103(2):189-94. PubMed ID: 10696914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.
    Xu H; Strassmann G; Chan CC; Rizzo LV; Silver PB; Wiggert B; Caspi RR
    Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):942-50. PubMed ID: 10102291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of monoclonal antibodies directed at cell surface molecules on murine experimental autoimmune uveoretinitis.
    Ando K; Fujino Y; Mochizuki M
    Graefes Arch Clin Exp Ophthalmol; 1999 Oct; 237(10):848-54. PubMed ID: 10502060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
    Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous nitric oxide inhibits experimental autoimmune uveoretinitis development in Lewis rats by modulation of the Th1-dependent immune response.
    Kwak HJ; Yang YS; Pae HO; Kim YM; Chung HT
    Mol Cells; 2001 Oct; 12(2):178-84. PubMed ID: 11710518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suramin treatment suppresses induction of experimental autoimmune uveoretinitis (EAU) in rodents.
    Sartani G; Silver PB; Strassmann G; Chan CC; Caspi RR
    Curr Eye Res; 1995 Oct; 14(10):887-96. PubMed ID: 8549154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen-specific inhibition of experimental autoimmune uveoretinitis by bone marrow-derived immature dendritic cells.
    Jiang HR; Muckersie E; Robertson M; Forrester JV
    Invest Ophthalmol Vis Sci; 2003 Apr; 44(4):1598-607. PubMed ID: 12657598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of experimental autoimmune uveoretinitis by vasoactive intestinal peptide.
    Keino H; Kezuka T; Takeuchi M; Yamakawa N; Hattori T; Usui M
    Arch Ophthalmol; 2004 Aug; 122(8):1179-84. PubMed ID: 15302659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of experimental autoimmune uveitis by angiotensin II type 1 receptor blocker telmisartan.
    Okunuki Y; Usui Y; Nagai N; Kezuka T; Ishida S; Takeuchi M; Goto H
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2255-61. PubMed ID: 19136706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of experimental autoimmune uveoretinitis by pretreatment with a pathogenic peptide in liposome and anti-CD40 ligand monoclonal antibody.
    Namba K; Ogasawara K; Kitaichi N; Morohashi T; Sasamoto Y; Kotake S; Matsuda H; Iwabuchi K; Iwabuchi C; Ohno S; Onoé K
    J Immunol; 2000 Sep; 165(6):2962-9. PubMed ID: 10975803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide-mediated suppression of experimental autoimmune uveoretinitis in mice: development of a peptide vaccine.
    Kezuka T; Sakai J; Yokoi H; Takeuchi M; Okada A; Taguchi O; Usui M; Mizuguchi J
    Int Immunol; 1996 Aug; 8(8):1229-35. PubMed ID: 8918692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye.
    Wildner G; Thurau SR
    Eur J Immunol; 1995 May; 25(5):1292-7. PubMed ID: 7774632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses.
    Hohki S; Ohguro N; Haruta H; Nakai K; Terabe F; Serada S; Fujimoto M; Nomura S; Kawahata H; Kishimoto T; Naka T
    Exp Eye Res; 2010 Aug; 91(2):162-70. PubMed ID: 20420831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response.
    Takeuchi A; Usui Y; Takeuchi M; Hattori T; Kezuka T; Suzuki J; Okunuki Y; Iwasaki T; Haino M; Matsushima K; Usui M
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3753-60. PubMed ID: 16186359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumor necrosis factor alpha therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming.
    Sartani G; Silver PB; Rizzo LV; Chan CC; Wiggert B; Mastorakos G; Caspi RR
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2211-8. PubMed ID: 8843907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral administration of interferon-beta suppresses experimental autoimmune uveoretinitis.
    Suzuki J; Sakai J; Okada AA; Takada E; Usui M; Mizuguchi J
    Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):314-21. PubMed ID: 11981647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of experimental autoimmune uveoretinitis by systemic and subconjunctival adenovirus-mediated transfer of the viral IL-10 gene.
    De Kozak Y; Thillaye-Goldenberg B; Naud MC; Da Costa AV; Auriault C; Verwaerde C
    Clin Exp Immunol; 2002 Nov; 130(2):212-23. PubMed ID: 12390308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+CD25+ T regulatory cells induced by LPS-activated bone marrow dendritic cells suppress experimental autoimmune uveoretinitis in vivo.
    Siepmann K; Biester S; Plsková J; Muckersie E; Duncan L; Forrester JV
    Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):221-9. PubMed ID: 16741709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of experimental autoimmune uveoretinitis by transforming growth factor-beta 1 in B10. A mice].
    Kezuka T; Sakai J; Yokoi H; Fukai T; Usui M
    Nippon Ganka Gakkai Zasshi; 1997 Nov; 101(11):847-52. PubMed ID: 9396229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of experimental autoimmune uveoretinitis by monoclonal antibody to interleukin-12.
    Yokoi H; Kato K; Kezuka T; Sakai J; Usui M; Yagita H; Okumura K
    Eur J Immunol; 1997 Mar; 27(3):641-6. PubMed ID: 9079803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.